Human cytomegalovirus (HCMV) encodes several highly polymorphic envelope glycoproteins; however, the biological relevance of this polymorphism is unclear. Glycoprotein N (gN) is one member of this polymorphic protein family. Four major gN genotypes (gN1-4) have been identified. We have tested the hypothesis that the gN polymorphism represents a mechanism to evade a neutralizing antiviral antibody response. Four recombinant viruses that differed only in the expression of the gN genotype were constructed on the genetic background of HCMV strain AD169. Exchange of gN genotypes had a minor detectable influence on virus replication, gN expression and gN-gM complex formation. Randomly selected human sera were analysed for neutralizing activity against the recombinant viruses. Of these, 70 % showed no difference in neutralizing titre between the viruses, whereas 30 % showed strain-specific neutralization. Differences in 50 % neutralization titre reached .8-fold. Viruses expressing the gN4 genotype were neutralized significantly better than those expressing the other gN genotypes. Strain specificity, or lack thereof, could not be attributed to the presence or absence of anti-gN antibodies, as all sera contained antibodies reacting with gN (as determined by ELISA). Thus, polymorphism of gN could contribute to evasion of an efficient neutralizing-antibody response and facilitate reinfection in previously seropositive individuals.
INTRODUCTIONHuman cytomegalovirus (HCMV) is a significant cause of morbidity and mortality in immunocompromised individuals, such as transplant recipients, AIDS patients and newborns . A puzzling aspect of HCMV biology is the fact that a large number of genetically distinct HCMV strains circulate in the population (Chandler & McDougall, 1986;Chou, 1990;Rasmussen et al., 2002Rasmussen et al., , 2003Murphy et al., 2003;Pignatelli et al., 2003). The presence of more than one strain has been observed in immunocompetent persons, indicating the possibility of simultaneous coinfection with multiple different virus strains or reinfection in the presence of a functional immune response (Chandler et al., 1987;Bale et al., 1996;Schoppel et al., 1997;Boppana et al., 2001). In immunocompromised patients, reinfection may represent a clinically important problem, as a de novo adaptive immune response against the reinfecting strain is impaired. Clinical studies in transplant patients have supported the importance of HCMV reinfection in these patients (Grundy et al., 1988; Coaquette et al., 2004;Ishibashi et al., 2007). Moreover, in women who are seropositive for HCMV, reinfection with a different strain can lead to intrauterine transmission and symptomatic congenital infection (Boppana et al., 2001). In the closely related murine cytomegalovirus (MCMV), simultaneous or sequential infection with different virus strains results in mixed infections in immunocompetent mice (Farroway et al., 2005;Gorman et al., 2006). Thus, reinfection with different strains of cytomegalovirus is frequent in both immunocompetent and ...